Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Introduction Oestrogen receptor beta (ER-β) is abundantly expressed in breast cancer (BC), but its impact on neoadjuvant chemotherapy outcome is unknown. Patients and Methods Patients treated in the neoadjuvant GeparTrio trial with available tissue for immunohistochemical analyses were included. Nuc...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitz, Florian, Kümmel, Sherko, Lederer, Bianca, Solbach, Christine, Engels, Knut, Ataseven, Beyhan, Sinn, Bruno, Blohmer, Jens Uwe, Denkert, Carsten, Barinoff, Jana, Fisseler-Eckhoff, Annette, Loibl, Sibylle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805199/
https://www.ncbi.nlm.nih.gov/pubmed/31656321
http://dx.doi.org/10.1055/a-0987-9898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805199/
https://www.ncbi.nlm.nih.gov/pubmed/31656321
http://dx.doi.org/10.1055/a-0987-9898

Ejemplares similares